Plain-English translation of NCT07316101 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing an anti-fog suction device designed to keep the surgical lens clear during endoscopic pituitary tumor removal surgery. The device uses a gentle air stream and suction to prevent fogging and reduce the need to stop surgery to clean the lens. Researchers want to see if this device works better than the traditional method of spraying saline water on the lens.
During minimally invasive pituitary surgery, the surgeon's view can become cloudy from moisture buildup, forcing frequent pauses to clean the lens. This trial exists to determine whether the new treatment can reduce these interruptions, shorten surgery time, and potentially lower the risk of complications like infection.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will have either the anti-fog device or the standard water-spray method used during your scheduled pituitary surgery. The device is inserted through your nose alongside the surgical instrument and remains in place throughout the operation. After surgery, you will stay in the hospital for the typical 3–5 day recovery period and return for a routine check-up around day 7. The research team will track surgery duration, any pauses due to fogging, and test results before and after your operation.
AI-generated summary from trial data · Aug 5, 2026 · Not medical advice
China